Skip to main content
SpringerLink
Log in

The Pathophysiological Role and Therapeutic Implications of Platelet Activating Factor in Diseases of Aging

  • Review Article
  • Physiological Aspects of Aging
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Platelet activating factor (PAF) is a unique phosphoglyceride which possesses many potent biological activities relevant for the pathogenesis of diseases of the elderly. PAF is generated and released by numerous cell types and tissues and is rapidly metabolised through a well defined metabolic cycle. Its biological actions are mediated via direct and indirect stimulatory effects on target cells and tissues. The current knowledge of PAF and its role in cardiovascular disease, thromboembolism, cerebral ischaemia and neurodegenerative disorders are discussed in detail. It is likely, that in future, a better understanding of the pathophysiological and physiological roles of PAF will provide new strategies for the treatment of human diseases of aging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adamus WS, Heuer HO, Meade CJ, Schilling JC. Inhibitory effects of the new PAF acether antagonist WEB 2086 on pharmacologic changes induced by PAF inhalation in human beings. Clinical Pharmacology and Therapeutics 47: 456–462, 1990

    Article  PubMed  CAS  Google Scholar 

  • Archer CB, Page CP, Paul W, Morley J, McDonald DM. Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin. British Journal of Pharmacology 110: 45–52, 1984

    CAS  Google Scholar 

  • Barbaro JF, Zvaifler NJ. Antigen induced histamine release from platelets and rabbit producing PCA antibody. Proceedings. Society for Experimental Medicine 122: 1245–1247, 1966

    CAS  Google Scholar 

  • Barnes PJ, Chung KF, Page CP. Platelet activating factor as a mediator of allergic disease. Journal of Allergy and Clinical Immunology 81: 919–934, 1989

    Article  Google Scholar 

  • Benveniste J, Boullet C, Brink C, Labat C. The action of PAF acether (platelet activating factor) on guinea pig isolated heart preparations. British Journal of Pharmacology 80: 81–83, 1983

    Article  PubMed  CAS  Google Scholar 

  • Benveniste J, Chignard M. A role for PAF-acether (platelet activating factor) in platelet-dependent vascular disease. Circulation 72: 713–717, 1985

    Article  PubMed  CAS  Google Scholar 

  • Benveniste J, Henson PM, Cochrane CG. Leucocyte dependent histamine release from rabbit platelets: the role of IgE, basophils, and a platelet activating factor. Journal of Experimental Medicine 136: 1356–1377, 1972

    Article  PubMed  CAS  Google Scholar 

  • Benveniste J, Tence M, Varenne P, Bidault J, Boullet C, et al. Semisynthesis et structure proposee du facteur activant les plaquettes (PAF): PAF-acether, un alkyl ether analoque de la lysophosphatidylcholine. Comptes Rendus. Academie des Seances 289: 1037–1040, 1979

    CAS  Google Scholar 

  • Birkle DL, Kurian P, Braquet P, Bazan NG. Platelet-activating factor antagonist BN 52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. Journal of Neurochemistry 51: 1900–1905, 1988

    Article  PubMed  CAS  Google Scholar 

  • Blank ML, Snyder F, Byers LW, Brooks B. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochemical and Biophysical Research Communications 90: 1194–1200, 1979

    Article  PubMed  CAS  Google Scholar 

  • Blank ML, Snyder F, Byers WL, Brooks B, Muirhead EE. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochemical and Biophysical Research Communications 90: 523–534, 1979

    Article  Google Scholar 

  • Bjork J, Smedegard G. Acute microvascular effects of PAF-acether as studied by intravital microscopy. European Journal of Pharmacology 96: 87–93, 1985

    Article  Google Scholar 

  • Bourgain R, Maes L, Braquet P, Andries R, Touqui L, et al. The effect of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on the arterial wall. Prostaglandins 30: 185–197, 1985

    Article  PubMed  CAS  Google Scholar 

  • Bourgain R, Vermarien H, Andries R, Touqui L, Braquet M. A standardized ‘in vivo’ model for the study of experimental arterial thrombosis. Description of the method. Advances in Experimental Medicine and Biology 180: 653–649, 1984

    Google Scholar 

  • Braquet P, Shen TY, Touqui L, Vargaftig BB. Perspectives in platelet activating factor research/Pharmacological Reviews 39: 97–145, 1987

    CAS  Google Scholar 

  • Brock TA, Gimbrone MA. Platelet activating factor alters calcium hemostasis in cultured endothelial cells. American Journal of Physiology 250: 1086–1092, 1986

    Google Scholar 

  • Bruynzell PLB, Koenderman PTM, Kok ML, Hameling ML, Verhagen J. Platelet activating factor induces leukotriene C4 formation and luminol dependent chemoluminescence by human eosinophils. Pharmacological Research Communications 18: 61–67, 1986

    Article  Google Scholar 

  • Burhop RE, van der Zee, Bisios R. Pulmonary vascular responses to platelet activating factor in awake sheep and the role of cyclooxygenase metabolites. American Review of Respiratory Diseases 134: 584–554, 1986

    Google Scholar 

  • Clerk De F, Gorp LV, Xhonneux B, Sommers Y, Wouters L. Enhanced platelet turnover and prostaglandin production in spontaneously hypertensive rats. Thrombosis Research 27: 243–249, 1982

    Article  Google Scholar 

  • Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet activating factor: evidence for 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active compound (a new class of lipid mediators). Journal of Biological Chemistry 254: 9355–9358, 1979

    PubMed  CAS  Google Scholar 

  • Dent G, Ukena D, Barnes PJ. PAF receptors. In Barnes et al. (Eds) Platelet activating factor and human disease, pp. 58–81, Blackwell Scientific Publications, Oxford, 1989

    Google Scholar 

  • D’Humieres S, Russo-Marie F, Vargaftig BB. PAF-acether-induced synthesis of prostaglandin by human endothelial cells. European Journal of Pharmacology 131: 13–19, 1986

    Article  PubMed  Google Scholar 

  • Dykens JA, Stern A, Trenkner E. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. Journal of Neurochemistry 49: 1222–1228, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ezra D, Laurindo FRM, Czaja JF, Snyder F, Goldstein RE, et al. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. Prostaglandins 34: 41–57, 1987

    Article  PubMed  CAS  Google Scholar 

  • Fasules J, Stenmark KR, Henson PM, Voelkel NE, Tucker A, Reves J. Platelet activating factor in lung lavage of chronically hypoxic neonatal calves. American Review of Respiratory Disease 133: A277, 1986

    Google Scholar 

  • Feuerstein G, Boyd LH, Azra D, Goldstein RE. Effect of platelet activating factor on coronary circulation of the domestic pig. American Journal of Physiology 246: 466–471, 1984

    Google Scholar 

  • Feuerstein G, Lux WE, Ezra D, Hayes EC, Snyder F, et al. Thyrotropin releasing hormone blocks the hypotensive effect of platelet activating factor in the unanesthetized guinea pig. Journal of Cardiovascular Pharmacology 7: 335–340, 1985

    Article  PubMed  CAS  Google Scholar 

  • Feuerstein G, Zukowska-Grojec L, Krausz M, Blank ML, Snyder F, et al. Cardiovascular and sympathetic effects of l-O-hexadecyl2-acetyl-sn-glycero-3-phosphorylcholine in conscious SHR and WKY rats. Clinical and Experimental Hypertension 4: 1335–1350, 1982

    Article  CAS  Google Scholar 

  • Fuxe K, Roberts P, Schwarcz R. Excitotoxins, Macmillan, London, 1983

    Google Scholar 

  • Giembycz M, Kroegel C, Barnes PJ. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins. Journal of Immunology 144: 157–158, 1990

    Google Scholar 

  • Guinot P, Summerhayes C, Berad L, Duchier J, Revillaud RJ. Treatment of adult systemic mastocytsis with a PAF-acether antagonist BN 52063. Lancet 2: 114, 1988

    Article  PubMed  CAS  Google Scholar 

  • Handley DA, Lee ML, Saunders RN. Evidence for a direct effect on vascular permeability of platelet activating factor induced hemoconcentration in the guinea pig. Thrombosis and Hemostasis 54: 756–759, 1985

    CAS  Google Scholar 

  • Hartung HP. Acetyl glyceryl ether phosphorylcholine (platelet activating factor) mediates heightened metabolic activity in macrophages. Febs Letters 160: 209–212, 1983

    Article  PubMed  CAS  Google Scholar 

  • Hayes JP, Ridge SM, Griffith S, Barnes PJ, Chung KF. Inhibition of cutaneous and platelet responses to platelet activating factor by oral WEB 2086 in man. Journal of Allergy and Clinical Immunology 88: 83–88, 1991

    Article  PubMed  CAS  Google Scholar 

  • Henson PM. Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leucocytes and antigen. Journal of Experimental Medicine 131: 287–306, 1970

    Article  PubMed  CAS  Google Scholar 

  • Hosford D, Page CP, Barnes PJ, Braquet P. PAF-receptor antagonists. In Barnes PJ, et al. (Eds) Platelet activating factor in human disease, pp. 82–116, Blackwell Scientific Publications, Oxford, London, Edinburgh, 1989

    Google Scholar 

  • Humphrey DM, McManus LM, Hanahan DJ, Pinckard RN. Morphological basis of increased vascular permeability induced by acetyl-glyceryl ether phosphorylcholine. Laboratory Investigation 50: 16–25, 1984

    PubMed  CAS  Google Scholar 

  • Inarrea P, Gomez-Cambronero J, Pascual J, Carmen Ponte M, delHernando L, et al. Synthesis of PAF-acether and blood volume changes in Gram-negative sepsis. Immunopharmacology 9: 4552, 1985

    Article  Google Scholar 

  • Jackson CV, Schumacher WA, Kunkel SL, Drisoll EM, Pope TK, et al. Platelet activating factor release of platelet-derived coronary artery vasodilator substance in the canine. Circulation Research 58: 218–229, 1986

    Article  PubMed  CAS  Google Scholar 

  • Jenner P. Neurotoxins and their pharmacological implications, Raven Press, New York, 1987

    Google Scholar 

  • Kochanek PM, Dutka AJ, Kumaroo KK, Hallenbeck JM. Platelet activating factor receptor blockade enhances neuronal recovery after multi-focal brain ischemia in dogs. Life Sciences 41: 2639–2644, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kochanek PM, Nemoto EM, Melick JA, Evans RW, Burke DF. Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet activating factor in rats. Journal of Cerebral Blood Flow and Metabolism 8: 546–551, 1988

    Article  PubMed  CAS  Google Scholar 

  • Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. Platelet activating factor (PAF): a review of its effects, antagonists and possible future clinical implications (Part I). Drugs 42: 9–29, 1991a

    Article  PubMed  CAS  Google Scholar 

  • Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. PAF: A review of its effects, antagonists and possible future clinical implications (Part II). Drugs 42: 174–204, 1991b

    Article  PubMed  CAS  Google Scholar 

  • Kornecki E, Ehrlich YH. Neuroregulatory and neuropathological actions of the ether-phospholipid platelet activating factor. Science 240: 1792–1794, 1988

    Article  PubMed  CAS  Google Scholar 

  • Kroegel C. The potential pathophysiological role of the platelet activating factor (PAF) in human disease. Klinische Wochenschrift 66: 373–378, 1988

    Article  PubMed  CAS  Google Scholar 

  • Kroegel C. Molecular mechanisms of stimulus-response coupling in human and guinea pig eosinophils. Transduction pathways utilized by platelet activating factor and their relationship to cellular effector functions. PhD Thesis, University of London, 1991a

  • Kroegel C, Chilvers ER, Giembycz MA, Challis RAJ, Barnes PJ. Platelet activating factor stimulates a rapid accumulation of inositol(1,4,5)trisphosphate in guinea pig eosinophils: relationship to calcium mobilization and degranulation. Journal of Allergy and Clinical Immunology 88: 114–124, 1991b

    Article  PubMed  CAS  Google Scholar 

  • Kroegel C, Hubbard WH, Lichtenstein LM. Spectrum of prostanoid generation by human blood eosinophils stimulated with platelet activating factor and calcymicin. European Journal of Respiratory Disease 3: 347, 1990

    Google Scholar 

  • Kroegel C, Yukawa T, Dent G, Venge P, Chung KF, et al. Stimulation of degranulation from human eosinophils by platelet activating factor. Journal of Immunology 142: 3518–3526, 1989

    CAS  Google Scholar 

  • Lai FM, Sheperd CA, Cervoni P, Wissner A. Hypotensive and vasodilatory activity of (+)-1-0-octadecyl-2-acetyl-glyceryl-3phosphorylcholine in the normotensive rat. Life Sciences 32: 1159–1166, 1983

    Article  PubMed  CAS  Google Scholar 

  • Lepran I, Lefer AM, Ischemia aggravating effects of platelet activating factor in acute myocardial ischemia. Basic Research in Cardiology 80: 135–141, 1985

    Article  PubMed  CAS  Google Scholar 

  • Lindsberg P, Jacobs TP, Paakari IA, Hallenberg JM, Feuerstein G. Effect of PAF-acether on spinal cord microcirculation. FASEB Journal 2: 455, 1988

    Google Scholar 

  • MacDermott AB, Mayer ML, Westbrook GL, Smith JL, NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 324: 519–522, 1986

    Article  Google Scholar 

  • McCormack DM, Barnes PJ, Evans TW, Evidence for platelet activating factor as a mediator of hypoxic pulmonary vasoconstriction. Clinical Science 75: 21, 1988

    Google Scholar 

  • McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN. Pathobiology of intravenous infusion of acetylglyceryletherphosphorylcholine (AGEPC), a synthetic platelet activating factor (PAF) in the rabbit. Journal of Immunology 124: 2919–2924, 1980

    CAS  Google Scholar 

  • McMurtry IF, Morris KG. Platelet activating factor causes pulmonary vasodilatation in the rat. American Review of Respiratory Diseases 134: 757–762, 1986

    CAS  Google Scholar 

  • Mehta J, Wargovich T, Nichols WW. Biphasic effects of platelet activating factor on coronary blood flow in the anesthetized dog. Prostaglandins Leukotrienes Medicine 21: 87–95, 1986

    Article  CAS  Google Scholar 

  • Mickelson JK, Simpson PJ, Lucchesi BR. Myocardial dysfunction and coronary vasoconstriction induced by platelet activating factor in post-infarcted isolated heart. Journal of Molecular and Cellular Cardiology 20, 547–561, 1988

    Article  PubMed  CAS  Google Scholar 

  • Nakaya H, Tohse N. Electrophysiological effects of acethylglyceryletherphosphocholine on cardiac tissue. Comparison with lysophosphatidylcholine and long chain acyl carnitine. British Journal of Pharmacology 89: 749–757, 1986

    Article  PubMed  CAS  Google Scholar 

  • Panetta T, Marcheselli V, Braquet P, Spinnewyn B, Bazan NG. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochemical and Biophysical Research Communications 149: 580–587, 1987

    Article  PubMed  CAS  Google Scholar 

  • Piper P, Stewart AG. Coronary vasoconstriction in the rat isolated perfused heart induced by platelet activating factor is mediated by leukotriene C4. British Journal of Pharmacology 81: 595–605, 1986

    Article  Google Scholar 

  • Piper P, Stewart AG. Antagonism of vasoconstriction induced by platelet activating factor in guinea pig perfused hearts by a selective platelet activating factor receptor antagonist. British Journal of Pharmacology 90: 771–783, 1987

    Article  PubMed  CAS  Google Scholar 

  • Prevost MV, Cariven C, Simon MF, Chap H, Douste-Blazy L. Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia. Biochemical and Biophysical Research Communications 119: 58–63, 1984

    Article  PubMed  CAS  Google Scholar 

  • Roberts NM, Page CP, Chung KF, Barnes PJ. Effect of a PAF antagonist, BN 52063, on antigen induced, acute and late onset cutaneous responses in atopic subjects. Journal of Allergy and Clinical Immunology 136: 623–627, 1989

    Google Scholar 

  • Robertson DA, Genovese A, Levi R. Negative inotrope effect of platelet activating factor on human myocardium: a pharmacological study. Journal of Pharmacology and Experimental Therapeutics 243: 834–839, 1987

    PubMed  CAS  Google Scholar 

  • Robertson DA, Wang DY, Lee COK, Levi R. Negative inotrope effect of platelet activating factor: association with a decrease in intracellular sodium activity. Journal of Pharmacology and Experimental Therapeutics 245: 124–128, 1988

    PubMed  CAS  Google Scholar 

  • Siraganian RP, Osier A. Destruction of rabbit platelets in the allergic response of sensitized leucocytes: demonstration of a fluid phase intermediate. Journal of Immunology 106: 1244–1251, 1971

    CAS  Google Scholar 

  • Siren AL, Feuerstein G. Effects of platelet activating factor and its antagonist, BN 52021, on cardiac function and regional blood flow in the conscious rat. American Journal of Physiology, in press, 1992

    Google Scholar 

  • Soling HD, Eibl H, Fest W. Acetylcholine-like effects of 1-0-alkyl2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its analogues in exocrine secretory glands. European Journal of Biochemistry 144: 65–72, 1984

    Article  PubMed  CAS  Google Scholar 

  • Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P. Involvement of platelet activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. Prostaglandins 34: 337–346, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tamargo J, Tejerina T, Delgado C, Barrigon S. Electrophysiological effects of platelet activating factor (PAF-acether) in guinea pig papillary muscle. European Journal of Pharmacology 109: 219–227, 1985

    Article  PubMed  CAS  Google Scholar 

  • Vargaftig BB, Lefort J, Chirgnard M, Benveniste J. Platelet activating factor induces a platelet dependent bronchoconstriction unrelated to the formation of prostaglandin derivates. European Journal of Pharmacology 65: 185–192, 1980

    Article  PubMed  CAS  Google Scholar 

  • Voelkel N, Worthen S, Reeves J, Henson P, Murphy R. Nonimmunologic production of leukotrienes induced by platelet activating factor. Science 218: 286–288, 1985

    Article  Google Scholar 

  • Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. Journal of Clinical Investigation 78: 1701–1706, 1986

    Article  PubMed  CAS  Google Scholar 

  • Wilkens JH, Wilkens H, Uffmann J, Bovers J, Fabel H, et al. Effects of a specific PAF-antagonist (BN 52063) on bronchoconstriction and platelet activation during exercise induced asthma. British Journal of Clinical Pharmacology 29: 85–91, 1990

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman GA, McIntyre TM, Prescott SM. Production of platelet activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. Circulation 72: 718–727, 1985

    Article  PubMed  CAS  Google Scholar 

  • Zukowska-Grojec Z, Blank ML, Snyder F, Feuerstein G. The adrenergic system and the cardiovascular effects of platelet activating factor (1-0-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) in SHR and WKY rats. Clinical and Experimental Hypertension 7: 1015–1031, 1985

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Institutes, Department of Pneumology, Robert-Koch-Clinic, Albert-Ludwigs-University, Hugstetter Str. 55, D-7800, Freiburg, Federal Republic of Germany

    Claus Kroegel, Cornelius Kortsik, Nasim Kroegel & Heinrich Matthys

Authors
  1. Claus Kroegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cornelius Kortsik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nasim Kroegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heinrich Matthys
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kroegel, C., Kortsik, C., Kroegel, N. et al. The Pathophysiological Role and Therapeutic Implications of Platelet Activating Factor in Diseases of Aging. Drugs & Aging 2, 345–355 (1992). https://doi.org/10.2165/00002512-199202040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199202040-00007

Keywords

Search

Navigation